Achillion Pharmaceuticals (ACHN) Posts Q4 EPS Loss

Achillion Pharmaceuticals, Inc. (ACHN) reported fourth quarter EPS of ($0.21) before the opening bell Thursday, compared to the consensus estimate of ($0.18). Net loss for the three months ended December 31, 2014 came in at $21.6 million, compared to a net loss of $13.4 million in 4Q/13. The stock is currently down nearly 9% to […] View the full post at: Achillion Pharmaceuticals (ACHN) Posts Q4 EPS Loss No related posts.